Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Lexaria Bioscience (LEXX) over the last 15 years, with Q4 2025 value amounting to $687678.0.

  • Lexaria Bioscience's Non-Current Assets fell 2896.13% to $687678.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $687678.0, marking a year-over-year decrease of 2896.13%. This contributed to the annual value of $706776.0 for FY2025, which is 2712.17% down from last year.
  • Lexaria Bioscience's Non-Current Assets amounted to $687678.0 in Q4 2025, which was down 2896.13% from $706776.0 recorded in Q3 2025.
  • Lexaria Bioscience's Non-Current Assets' 5-year high stood at $1.2 million during Q1 2021, with a 5-year trough of $687678.0 in Q4 2025.
  • In the last 5 years, Lexaria Bioscience's Non-Current Assets had a median value of $893525.5 in 2021 and averaged $897861.4.
  • In the last 5 years, Lexaria Bioscience's Non-Current Assets soared by 5207.95% in 2021 and then plummeted by 3129.4% in 2022.
  • Over the past 5 years, Lexaria Bioscience's Non-Current Assets (Quarter) stood at $844546.0 in 2021, then rose by 1.13% to $854110.0 in 2022, then grew by 9.25% to $933140.0 in 2023, then grew by 3.74% to $968033.0 in 2024, then dropped by 28.96% to $687678.0 in 2025.
  • Its last three reported values are $687678.0 in Q4 2025, $706776.0 for Q3 2025, and $934588.0 during Q2 2025.